Package 0069-0809-01

{"route": ["INTRAVENOUS"], "spl_id": "421960f4-55cd-4bf8-9f00-b980b020e7a7", "openfda": {"nui": ["N0000175610", "N0000175451"], "upc": ["0300690809014"], "unii": ["B72HH48FLU"], "rxcui": ["1790541", "1790546"], "spl_set_id": ["37eaca10-d812-48bc-8b8e-b836bfa9968f"], "pharm_class_epc": ["Tumor Necrosis Factor Blocker [EPC]"], "pharm_class_moa": ["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (0069-0809-01)  / 10 mL in 1 VIAL, SINGLE-USE", "package_ndc": "0069-0809-01", "marketing_start_date": "20161121"}], "brand_name": "INFLECTRA", "product_id": "0069-0809_421960f4-55cd-4bf8-9f00-b980b020e7a7", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Tumor Necrosis Factor Blocker [EPC]", "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "product_ndc": "0069-0809", "generic_name": "infliximab-dyyb", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "INFLECTRA", "active_ingredients": [{"name": "INFLIXIMAB", "strength": "100 mg/10mL"}], "application_number": "BLA125544", "marketing_category": "BLA", "marketing_start_date": "20161121", "listing_expiration_date": "20261231"}